39853935|t|NOTCH3 Mutation Causes Glymphatic Impairment and Promotes Brain Senescence in CADASIL.
39853935|a|AIMS: The aim of this study is to investigate the role of glymphatic function of cerebral autosomal dominant arteriopathy, subcortical infarcts, and leukoencephalopathy (CADASIL), the most common monogenic small vessel disease caused by NOTCH3 mutation, and to explore potential therapeutic strategies to improve glymphatic function. METHODS: We assessed glymphatic influx and efflux function in CADASIL mouse models (Notch3R170C) and correlated these findings with brain atrophy in CADASIL patients. We also investigated the underlying mechanisms of glymphatic impairment, focusing the expression of AQP4 in astrocytic endfeet. RESULTS: CADASIL mouse exhibited both impaired glymphatic influx and efflux, which impedes waste clearance and promotes brain senescence. In accordance, brain atrophy in CADASIL patients is associated with perivascular space enlargement, indicating that glymphatic impairment contributes to advanced brain senescence in CADASIL. The glymphatic malfunction in CADASIL is attributed to diminished AQP4 expression in astrocytic endfeet, which is the core mediator of glymphatic activity. Mechanistically, AQP4 expression is regulated by NOTCH3-RUNX1-CMYB signaling. Reinforcing AQP4 expression in astrocytes by AAV-based therapy resumes the glymphatic functions in CADASIL mice, which further prevents brain senescence. CONCLUSION: We propose that to improve glymphatic function by reinforcing AQP4 expression is a promising therapeutic strategy in CADASIL.
39853935	0	6	NOTCH3	Gene	18131
39853935	23	44	Glymphatic Impairment	Disease	MESH:D060825
39853935	64	74	Senescence	Disease	OMIM:615513
39853935	78	85	CADASIL	Disease	MESH:D046589
39853935	168	255	cerebral autosomal dominant arteriopathy, subcortical infarcts, and leukoencephalopathy	Disease	MESH:D046589
39853935	257	264	CADASIL	Disease	MESH:D046589
39853935	293	313	small vessel disease	Disease	MESH:D059345
39853935	324	330	NOTCH3	Gene	18131
39853935	483	490	CADASIL	Disease	MESH:D046589
39853935	491	496	mouse	Species	10090
39853935	511	516	R170C	ProteinMutation	tmVar:p|SUB|R|170|C;HGVS:p.R170C;VariantGroup:0;OriginalGene:18131;CorrespondingGene:4854;CorrespondingSpecies:10090
39853935	553	566	brain atrophy	Disease	MESH:C566985
39853935	570	577	CADASIL	Disease	MESH:D046589
39853935	578	586	patients	Species	9606
39853935	638	659	glymphatic impairment	Disease	MESH:D060825
39853935	688	692	AQP4	Gene	11829
39853935	725	732	CADASIL	Disease	MESH:D046589
39853935	733	738	mouse	Species	10090
39853935	842	852	senescence	Disease	OMIM:615513
39853935	869	882	brain atrophy	Disease	MESH:C566985
39853935	886	893	CADASIL	Disease	MESH:D046589
39853935	894	902	patients	Species	9606
39853935	970	991	glymphatic impairment	Disease	MESH:D060825
39853935	1022	1032	senescence	Disease	OMIM:615513
39853935	1036	1043	CADASIL	Disease	MESH:D046589
39853935	1075	1082	CADASIL	Disease	MESH:D046589
39853935	1111	1115	AQP4	Gene	11829
39853935	1218	1222	AQP4	Gene	11829
39853935	1250	1256	NOTCH3	Gene	18131
39853935	1257	1262	RUNX1	Gene	12394
39853935	1263	1267	CMYB	Gene	17863
39853935	1291	1295	AQP4	Gene	11829
39853935	1378	1385	CADASIL	Disease	MESH:D046589
39853935	1386	1390	mice	Species	10090
39853935	1421	1431	senescence	Disease	OMIM:615513
39853935	1507	1511	AQP4	Gene	11829
39853935	1562	1569	CADASIL	Disease	MESH:D046589
39853935	Association	11829	18131
39853935	Negative_Correlation	OMIM:615513	11829
39853935	Association	11829	17863
39853935	Association	12394	18131
39853935	Association	12394	17863
39853935	Association	17863	18131
39853935	Association	MESH:D046589	18131
39853935	Association	11829	12394
39853935	Association	MESH:D060825	18131
39853935	Association	MESH:D046589	11829
39853935	Association	OMIM:615513	18131

